EluNIR Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study

NCT03877848 · clinicaltrials.gov ↗
COMPLETED
Status
319
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Medinol Ltd.